Clinical Trial Update: Clinical Study of Retagliptin Phosphate Combined With Metformin in the Treatment of Type 2 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating retagliptin phosphate combined with metformin for Type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Retagliptin Phosphate (retagliptin phosphate)
• metformin (metformin)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Type 2 Diabetes | Phase 3 | Status: UNKNOWN